Nanomedicine News

RSS

Degradable Nanoscale Shell Carries Proteins to Cancer Cells

Scientists create nanoscale vehicle to battle cancer without harming healthy cells

7 Feb 2013

Red Blood Cells Trap Drug-Carrying Nanoparticles

Many medically minded researchers are in hot pursuit of designs that will allow drug-carrying nanoparticles to navigate tissues and the interiors of cells, but University of Michigan engineers have discovered that these particles have another hurdle to overcome: escaping the bloodstream.

6 Feb 2013

Celsion Updates Status of its Patent Application ‘Method of Storing Nanoparticle Formulations’

Celsion Corporation today announced that Zheijang HISUN Pharmaceutical Company (HISUN) does not plan to pursue the exclusive option to license ThermoDox® for the Greater China market. Accordingly, the parties will not enter into the exclusive license agreement, and Celsion will not receive nor will it require any future payment for the option or license, as contemplated in the Exclusive Option Agreement announced on January 22, 2013.

6 Feb 2013

Nanodermatology Society Proclaims 2013 as the Year of Topical Delivery

For over a century, each year has been marked by extraordinary progress in both medicine and biotechnology. Just one hundred years ago, Nicholay Anichkov made the earliest link between cholesterol and atherosclerosis, an...

6 Feb 2013

Alnylam Licenses PCS Cholesterol Program with Lipid Nanoparticle Delivery Technology to Medicines Company

As we told our readers last week, industry observers and Wall Street Analysts both feel that the RNAi space will heat up significantly in 2013. To that point, both Alnylam Pharmaceuticals, Inc and Tekmira Pharmaceuticals Corporation started February off with news.

5 Feb 2013

Tekmira Lipid Nanoparticle Delivery Technology Phase 1 Study to be Presented at AACR

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today that it has been selected as an oral presenter at the annual meeting of the American Association for Cancer Research (AACR) taking place in Washington, DC from April 6-10, 2013.

5 Feb 2013

Pharmsyntez to Distribute Oasmia’s Nanoparticle Anti-Cancer Formulation in Russia and CIS Countries

Pharmsyntez obtains exclusive marketing and distribution rights in Russia and the countries encompassed by the Commonwealth of Independent States (CIS), and the agreement includes profit sharing on net sales in the region between the two companies.

5 Feb 2013

Gold-Plated Nanoparticle Transports Radioactive Particles Directly to Tumors

We've all heard that "it's not wise to use a cannon to kill a mosquito." But what if you could focus the cannon's power to concentrate power into a tiny space? In a new study, University of Missouri researchers have demonstrated the ability to harness powerful radioactive particles and direct them toward small cancer tumors while doing negligible damage to healthy organs and tissues. The study is being published this week in PLOS ONE, an international, peer-reviewed and open-access publication.

5 Feb 2013

Smithers Rapra Releases Update on Gold Nanoparticles

Smithers Rapra Publishing announces the release of Update on Gold Nanoparticles: From Cathedral Windows to Nanomedicine. In the last decade, gold nanoparticles have provided a suitable platform for the development of ...

4 Feb 2013

Unique Nanomechanical Signature Shows Promise to Improve Cancer Treatment

The texture of breast cancer tissue differs from that of healthy tissue. Using a cutting-edge tissue diagnostic device, a group of researchers in Basel, Switzerland, has determined one key difference: cancerous tissue is a mix of stiff and soft zones, whereas healthy tissue has uniform stiffness.

2 Feb 2013